Recent

% | $
Quotes you view appear here for quick access.

Biogen Inc. Message Board

  • optionadventure optionadventure Sep 10, 2013 3:48 PM Flag

    BIIB earnings will blow through 240/250....

    on profits from their new MS drug Tecfedera alone, never mind the new research. MS patients are dropping the injectibles like mad and Tecfedera instead. 60% relapse rate and very safe AND it really helps. Believe me....I know....I take it. The couple of PML reports are misleading...people were weakened and sick from other drugs. Tecfedera is a life saver and new MS reversal drugs are in the pipeline.

    Sentiment: Strong Buy

 
BIIB
398.68-2.47(-0.62%)May 22 4:00 PMEDT